Page 2 of 15 · 360 questions tagged semaglutide.
Conditions: SURMOUNT-4 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Concretely: SOUL · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
Setup, so nobody has to ask: STEP 3 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
Concretely: PIONEER-4 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Concretely: ESSENCE · tirzepatide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
Conditions: SURMOUNT-5 · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: a GLP-1 receptor agonist · cagrilintide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
Details up front: cagrilintide · liraglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The specifics, since they change the answer: STEP 8 · survodutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…
What I have: SURMOUNT-OSA · retatrutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I have: SURMOUNT-OSA · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
Numbers first: REDEFINE-1 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Setup, so nobody has to ask: STEP 4 · mazdutide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
Stated plainly: SUSTAIN-6 · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
The argument I keep encountering for splitting a weekly dose into two half-doses three or four days apart is that it lowers the peak and raises the trough, and that a…
Setup, so nobody has to ask: STEP 4 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary…
Conditions: semaglutide · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Setup, so nobody has to ask: STEP 3 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary…
Setup, so nobody has to ask: ESSENCE · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the…
What I am working with: retatrutide · retatrutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
Concretely: SOUL · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
What I am working with: SURMOUNT-5 · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The US labelling for several drugs in this class carries a boxed warning about thyroid C-cell tumours, and it is stated fairly starkly — tumours in both rats and…
Down 18% of body weight over ten months. My triglycerides have collapsed from 3.1 to 1.1 mmol/L, which is the change everyone predicted. My LDL-C has gone from 3.4 to…